<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1F50F60B-9F9F-4A5E-BB54-82D09A571D54"><gtr:id>1F50F60B-9F9F-4A5E-BB54-82D09A571D54</gtr:id><gtr:name>Biolamina</gtr:name><gtr:address><gtr:line1>L?fstr?m all? 5A</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/0CF6353C-24C9-4866-99CF-FB1DB633AF6F"><gtr:id>0CF6353C-24C9-4866-99CF-FB1DB633AF6F</gtr:id><gtr:name>University of North Carolina at Chapel Hill</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CD3E19D5-4099-43DB-A2D3-166143A8B059"><gtr:id>CD3E19D5-4099-43DB-A2D3-166143A8B059</gtr:id><gtr:name>Technical University of Dortmund</gtr:name><gtr:address><gtr:line1>Emil-Figge-Stra?e 72</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/BECA2763-0902-40AA-8DB2-836A5731CF58"><gtr:id>BECA2763-0902-40AA-8DB2-836A5731CF58</gtr:id><gtr:name>Brunel University</gtr:name><gtr:address><gtr:line1>Brunel University</gtr:line1><gtr:line4>Uxbridge</gtr:line4><gtr:line5>Middlesex</gtr:line5><gtr:postCode>UB8 3PH</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/EF0A0061-F60F-4692-947B-E406296939F5"><gtr:id>EF0A0061-F60F-4692-947B-E406296939F5</gtr:id><gtr:name>Chinese Academy of Sciences</gtr:name><gtr:address><gtr:line1>52 Sanlihe Road</gtr:line1><gtr:postCode>100864</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>MRC Centre for Regenerative Medicine</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1F50F60B-9F9F-4A5E-BB54-82D09A571D54"><gtr:id>1F50F60B-9F9F-4A5E-BB54-82D09A571D54</gtr:id><gtr:name>Biolamina</gtr:name><gtr:address><gtr:line1>L?fstr?m all? 5A</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/0CF6353C-24C9-4866-99CF-FB1DB633AF6F"><gtr:id>0CF6353C-24C9-4866-99CF-FB1DB633AF6F</gtr:id><gtr:name>University of North Carolina at Chapel Hill</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CD3E19D5-4099-43DB-A2D3-166143A8B059"><gtr:id>CD3E19D5-4099-43DB-A2D3-166143A8B059</gtr:id><gtr:name>Technical University of Dortmund</gtr:name><gtr:address><gtr:line1>Emil-Figge-Stra?e 72</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/BECA2763-0902-40AA-8DB2-836A5731CF58"><gtr:id>BECA2763-0902-40AA-8DB2-836A5731CF58</gtr:id><gtr:name>Brunel University</gtr:name><gtr:address><gtr:line1>Brunel University</gtr:line1><gtr:line4>Uxbridge</gtr:line4><gtr:line5>Middlesex</gtr:line5><gtr:postCode>UB8 3PH</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EF0A0061-F60F-4692-947B-E406296939F5"><gtr:id>EF0A0061-F60F-4692-947B-E406296939F5</gtr:id><gtr:name>Chinese Academy of Sciences</gtr:name><gtr:address><gtr:line1>52 Sanlihe Road</gtr:line1><gtr:postCode>100864</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C909EE39-7D96-4344-9514-CB7258D806F6"><gtr:id>C909EE39-7D96-4344-9514-CB7258D806F6</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Colin</gtr:otherNames><gtr:surname>Hay</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/BE22AA55-DA2E-4D89-AEF7-56C1607432A1"><gtr:id>BE22AA55-DA2E-4D89-AEF7-56C1607432A1</gtr:id><gtr:firstName>Stuart</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Forbes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C04DE242-FC3C-4D5A-B576-037A94215D60"><gtr:id>C04DE242-FC3C-4D5A-B576-037A94215D60</gtr:id><gtr:firstName>Ludovic</gtr:firstName><gtr:surname>Vallier</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/87E35D76-2708-48A4-B919-701CD6B350BC"><gtr:id>87E35D76-2708-48A4-B919-701CD6B350BC</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:surname>Callanan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/136DED6D-E7F0-4C3D-AF00-E7FECA1DFB63"><gtr:id>136DED6D-E7F0-4C3D-AF00-E7FECA1DFB63</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Bradley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2F70A533-1186-4870-9805-1913FA304DE0"><gtr:id>2F70A533-1186-4870-9805-1913FA304DE0</gtr:id><gtr:firstName>Anil</gtr:firstName><gtr:surname>Dhawan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1701F26B-544C-4E4A-ACF9-3E5F5AD90C8E"><gtr:id>1701F26B-544C-4E4A-ACF9-3E5F5AD90C8E</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:otherNames>N</gtr:otherNames><gtr:surname>Newsome</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FL022974%2F1"><gtr:id>4E5D0903-82A1-4831-AEA3-A83853ACFC4F</gtr:id><gtr:title>The development of 3-dimensional implantable liver organoids</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/L022974/1</gtr:grantReference><gtr:abstractText>Liver disease is the 5th most common cause of death in the UK. 16,087 people in the UK died from liver disease in 2008, a 4.5% increase since 2007 and trends are rising. Liver disease kills more people than diabetes and road deaths combined. The only curative option for end-stage cirrhosis and acute liver failure is liver transplantation, however organ availability cannot meet demand and many patients die waiting for an organ. Those who undergo transplantation require lifelong treatment with increased risks of infection, cancer, kidney and heart disease. Thus, there is a clear need to identify alternatives to liver transplantation. Recent studies have shown that human cells can small fragments of liver like tissue. While providing proof of concept, the tissue is very small and lacks key liver functions. To address this we have assembled a team with complementary expertise to reliably produce human liver tissue with clinically relevant function.</gtr:abstractText><gtr:technicalSummary>Liver disease is the 5th most common cause of death in the UK. 16,087 people in the UK died from liver disease in 2008, a 4.5% increase since 2007 and trends are rising. Liver disease kills more people than diabetes and road deaths combined (REF: Office for National Statistics: Health Service Quarterly, Winter 2008, No. 40 p59-60). The only curative option for end-stage cirrhosis and acute liver failure is liver transplantation, however organ availability cannot meet demand and many patients die waiting for an organ. Those who undergo transplantation require lifelong immunosuppression with concomitant risks of infection, cancer, renal and cardiovascular disease. Thus, there is a clear imperative to identify alternatives to liver transplantation. Recent studies have shown human pluripotent stem cells (hPSC) co-cultured with MSCs and endothelial cells can form primitive liver organoids (Takebe et al. Nature 2013). While providing proof of concept the in vitro derived spheroids are tiny and lack a functional biliary system, requiring transformative innovation before they can be used clinically. To deliver this we have assembled a team with complementary expertise in the production and use of stem cell derived hepatocyte and cholangiocytes-like cells, hepatocyte niche construction, three-dimensional scaffold production and in vivo modelling. This collaborative group includes scientists and clinicians with experience in human cell production, GMP cell production and clinical cell therapy for liver disease. This group is ideally placed to translate these pre-clinical observations into a therapy for patients with liver failure or metabolic liver diseases, and particularly the use of liver buds derived from genetically corrected iPS cells in the case of liver disease caused by single gene defects.</gtr:technicalSummary><gtr:potentialImpactText>This project will develop the technology needed to help advance the treatment of human liver disease by providing implantable devices for liver support. We envisage clinical utility in 4 settings: 
(a) Where acute liver injury had occurred (drug-induced or post-hepatectomy) and this liver support would support the patient until endogenous repair had occurred,
(b) In acute on chronic liver failure where the patient has been listed for transplantation but no suitable organ is immediately available- the aim would be to stabilise and support the patient until a suitable donor organ is available
(c) As rescue therapy in paediatric cases of inborn errors of liver metabolism where the lack of specific proteins in the patient hepatocytes can lead to multiple organ failure.
(d) The ability to model human disease 'in a dish' has revolutionary potential for new and safer drug design to treat liver disease and tissue regeneration.
The changeable genetic element within our system will allow for the tissue to be tailor-made for the recipient, obviating the need for immunosuppressive drugs (and their side effects). This type of disruptive technology will bolster economic development within the UK and maintain our position as a world leader in our respective scientific fields. Such improvements will have significant benefits in terms of direct and indirect healthcare costs, social and welfare costs. In addition, by addressing an unmet medical need, the project has a great potential for wealth creation for the UK. To develop the impacts we shall engage:
(i) Clinical practitioners and transplant surgeons
The consortium has strong clinical focus. Engagement with the relevant clinical practitioners and transplant surgeons has already been established. SJ Forbes, A Dhawan and PN Newsome are clinicians within 3 large UK liver transplant units covering both adult and paediatric liver patients. 
(ii) Cell based modeling to develop safer and new medicines
The consortium has built up a strong relationship with industry and is well positioned to deliver novel models for application. The benefits for the industry have the potential to be realised within only a few months of completion of the project. Academic research groups could also utilise the technology within a similar time frame. 
(iii) Government / Regulatory Authorities
The introduction of new treatments for liver disease or screening models will lead to the development of novel medicines, which will be managed in consultation with regulatory authorities that oversee drug safety, efficacy and cost. We have engaged with the Cell Therapy Catapult who see the merit of our application and have provided a letter of support.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-04-10</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2014-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1626381</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>Front cover - Best of Stem Cell Reports 2015</gtr:description><gtr:id>87337993-BD9B-42EE-9B3D-1BD11BA8660A</gtr:id><gtr:impact>Communication with peers</gtr:impact><gtr:title>Front cover - Best of Stem Cell Reports 2015</gtr:title><gtr:type>Artwork</gtr:type><gtr:url>http://onlinedigeditions.com/publication/frame.php?i=260435&amp;p=&amp;pn=&amp;ver=html5</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput><gtr:artisticAndCreativeProductOutput><gtr:description>Interview with lab tube TV</gtr:description><gtr:id>9BFED446-6D3F-4F3A-9624-2C5F4A02AE3C</gtr:id><gtr:impact>659 VIEWS</gtr:impact><gtr:title>Lab Tube TV interview</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:url>https://www.labtube.tv/video/labtube-meets-david-hay-mrc-centre-for-regenerative-medicine</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput><gtr:artisticAndCreativeProductOutput><gtr:description>Advanced Healthcare Materials Frontispiece</gtr:description><gtr:id>BA0DCB59-3EB9-44D4-BF8E-6BC2C8BC50B0</gtr:id><gtr:impact>Communication with peers</gtr:impact><gtr:title>Frontispiece</gtr:title><gtr:type>Artwork</gtr:type><gtr:url>http://onlinelibrary.wiley.com/doi/10.1002/adhm.201570072/abstract</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Biolamina</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Lamin driected differentiation</gtr:description><gtr:id>E63A0609-44DF-46A3-9506-36657865BBEF</gtr:id><gtr:impact>Recombinant Laminins Drive the Differentiation and Self-Organization of hESC-Derived Hepatocytes.
Cameron K, Tan R, Schmidt-Heck W, Campos G, Lyall MJ, Wang Y, Lucendo-Villarin B, Szkolnicka D, Bates N, Kimber SJ, Hengstler JG, Godoy P, Forbes SJ, Hay DC.
Stem Cell Reports. 2015 Dec 8;5(6):1250-62. doi: 10.1016/j.stemcr.2015.10.016. Epub 2015 Nov 25.
PMID: 26626180 

Patent application - METHODS FOR PRODUCING HEPATOCYTES - LCTI 200041USP1.</gtr:impact><gtr:partnerContribution>Provision of discounted recombinant laminins for use.</gtr:partnerContribution><gtr:piContribution>The collaboration has allowed us to produce better stem cell derived hepatocytes. We have protected our intellectual property with Biolamina - LCTI 200041USP1</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of North Carolina at Chapel Hill</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Microbiology and Immunology</gtr:department><gtr:description>HBV project</gtr:description><gtr:id>8B649725-DC5F-44B6-A9DD-D5353404AA37</gtr:id><gtr:impact>None as yet. The project is on going,</gtr:impact><gtr:partnerContribution>In vivo transplant of stem cell derived hepatocytes and HBV infection</gtr:partnerContribution><gtr:piContribution>Provision of stem cell derived hepatocytes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brunel University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Life Sciences</gtr:department><gtr:description>HCC Models in Stem Cell Derived Hepatocytes</gtr:description><gtr:id>CFF023E3-1A7A-44EA-A7BE-E41DF974CB54</gtr:id><gtr:impact>none as yet. We are in the process of preparing a phase II application to the NC3Rs.</gtr:impact><gtr:partnerContribution>Michael's team will make the HCC model at Brunel</gtr:partnerContribution><gtr:piContribution>We have provided training to Michael Thermis' lab to produce stem cell derived hepatocytes from hESC and IPSCs for modelling human HCC 'in a dish'</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chinese Academy of Sciences</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:department>Institute of Biochemistry and Cell Biology</gtr:department><gtr:description>iHep and iPSC Hep collaboration</gtr:description><gtr:id>957FCA0F-4A43-496C-966D-CEEE100DB13C</gtr:id><gtr:impact>Paper in preparation, to be submitted by Q2 2016</gtr:impact><gtr:partnerContribution>Validation of our stem cell differentiation procedures</gtr:partnerContribution><gtr:piContribution>Transfer of stem cell technology from UK to China</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technical University of Dortmund</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Leibniz Instituteiz</gtr:department><gtr:description>Hepatocyte Bioinformatics</gtr:description><gtr:id>D88CB7E7-73F8-4FD1-96CC-21EB503CC120</gtr:id><gtr:impact>2 manuscripts published - see publications</gtr:impact><gtr:partnerContribution>Expertise in gene arraying and bioinformatics</gtr:partnerContribution><gtr:piContribution>Provison of differing hepatocytes populations for analysis by gene array</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Chief Scientist Office (CSO)</gtr:department><gtr:description>Exploiting hepatocyte and endothelial cell interactions for the development of scalable human liver tissue.</gtr:description><gtr:end>2020-02-02</gtr:end><gtr:fundingOrg>Scottish Government</gtr:fundingOrg><gtr:id>F1211B9B-7401-40DA-9821-EF07C873DDA8</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Disclosed herein are methods for producing hepatocytes with more natural properties and more differentiated function. Generally, those methods comprise: plating pluripotent human stem cells on a cell culture substrate comprising (i) a first laminin which is laminin-521 and (ii) a second laminin selected from the group consisting of laminin-111 and laminin-221, wherein the laminin-521 and the second laminin are each either an intact protein or a protein fragment; and culturing the pluripotent human stem cells to obtain the hepatocytes. The resulting hepatocytes exhibit efficient hepatocyte specification, organisation, maturation and significant improvements in cell function and stability. It is believed that the laminins suppress inappropriate gene regulatory networks controlling cell proliferation, cell migration, stem cell self-renewal, and colon and fibroblast specification. The stem cells themselves should be research and GMP grade.</gtr:description><gtr:id>E17BEAB5-8EEA-412D-BD75-4178012E928D</gtr:id><gtr:impact>Numerous publications (detailed before)reproduced our press release.</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:patentId>LCTI 200041USP1</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>METHODS FOR PRODUCING HEPATOCYTES</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Comparing gene expression of adult human hepatocytes to stem cell derived hepatocytes</gtr:description><gtr:id>816393B8-4B39-4969-9D97-B373BC0C6697</gtr:id><gtr:impact>Other researchers around the world using this system as reference - Godoy et al Archives of Toxicol 2016, Mallanna et al 2016 Stem Cell Reports</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Stem cell differentiation bioinformatics</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3994/</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D3571F9F-2A21-4756-A31D-CBE0E108DC61"><gtr:id>D3571F9F-2A21-4756-A31D-CBE0E108DC61</gtr:id><gtr:title>Pluripotent stem cell derived hepatocytes: using materials to define cellular differentiation and tissue engineering.</gtr:title><gtr:parentPublicationTitle>Journal of materials chemistry. B, Materials for biology and medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/086161dc37d1dafc22f0ce3f56c5730f"><gtr:id>086161dc37d1dafc22f0ce3f56c5730f</gtr:id><gtr:otherNames>Lucendo-Villarin B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-750X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/69AB393E-196B-4FFA-B6D0-D00770C6A75F"><gtr:id>69AB393E-196B-4FFA-B6D0-D00770C6A75F</gtr:id><gtr:title>Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d6209ac943f79ade8817ded5731f2131"><gtr:id>d6209ac943f79ade8817ded5731f2131</gtr:id><gtr:otherNames>Godoy P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F305A9DF-5ABE-4666-A8D9-149B9683E0B7"><gtr:id>F305A9DF-5ABE-4666-A8D9-149B9683E0B7</gtr:id><gtr:title>Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7f098469dc1dbb18dc75ff4bb9372c1b"><gtr:id>7f098469dc1dbb18dc75ff4bb9372c1b</gtr:id><gtr:otherNames>Goldring C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D4493D03-28BC-478F-9847-CC38CACE4452"><gtr:id>D4493D03-28BC-478F-9847-CC38CACE4452</gtr:id><gtr:title>Prospective purification of perivascular presumptive mesenchymal stem cells from human adipose tissue: process optimization and cell population metrics across a large cohort of diverse demographics.</gtr:title><gtr:parentPublicationTitle>Stem cell research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1c18ffb88ef837b14a955292161ac668"><gtr:id>1c18ffb88ef837b14a955292161ac668</gtr:id><gtr:otherNames>West CC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1757-6512</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/99ADDFF7-3450-4384-8307-049AEAB8E699"><gtr:id>99ADDFF7-3450-4384-8307-049AEAB8E699</gtr:id><gtr:title>Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells</gtr:title><gtr:parentPublicationTitle>JOURNAL OF HEPATOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6655e45a06475db2e734382a184b09a9"><gtr:id>6655e45a06475db2e734382a184b09a9</gtr:id><gtr:otherNames>Godoy Patricio</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AAED0F9B-5A4B-4DCA-84D0-BEED62053C72"><gtr:id>AAED0F9B-5A4B-4DCA-84D0-BEED62053C72</gtr:id><gtr:title>Fluid shear stress modulation of hepatocyte-like cell function.</gtr:title><gtr:parentPublicationTitle>Archives of toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/da5e5440a6650973bed629a1415bbfcd"><gtr:id>da5e5440a6650973bed629a1415bbfcd</gtr:id><gtr:otherNames>Rashidi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-5761</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5721752D-7595-4623-BFCF-CDBFA49EE28A"><gtr:id>5721752D-7595-4623-BFCF-CDBFA49EE28A</gtr:id><gtr:title>Reducing Hepatocyte Injury and Necrosis in Response to Paracetamol Using Noncoding RNAs.</gtr:title><gtr:parentPublicationTitle>Stem cells translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/064747e3ad60014f784c7bd6ae22e431"><gtr:id>064747e3ad60014f784c7bd6ae22e431</gtr:id><gtr:otherNames>Szkolnicka D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2157-6564</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/988B69D1-45EB-46B0-9934-63A6D0B17DEA"><gtr:id>988B69D1-45EB-46B0-9934-63A6D0B17DEA</gtr:id><gtr:title>Polymer Supported Directed Differentiation Reveals a Unique Gene Signature Predicting Stable Hepatocyte Performance.</gtr:title><gtr:parentPublicationTitle>Advanced healthcare materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/88faafb158d268b797c8d4d26509a188"><gtr:id>88faafb158d268b797c8d4d26509a188</gtr:id><gtr:otherNames>Villarin BL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2192-2640</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AD6B6F92-118B-49B8-A0FD-EE6A77CD0B9C"><gtr:id>AD6B6F92-118B-49B8-A0FD-EE6A77CD0B9C</gtr:id><gtr:title>Serum-Free Directed Differentiation of Human Embryonic Stem Cells to Hepatocytes.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a58d69ad4f17dd544ce82aba3158212b"><gtr:id>a58d69ad4f17dd544ce82aba3158212b</gtr:id><gtr:otherNames>Cameron K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/01B0566E-C7E5-482A-9C20-9C4989A777F1"><gtr:id>01B0566E-C7E5-482A-9C20-9C4989A777F1</gtr:id><gtr:title>Mass production of stem cell derived human hepatocytes for experimental medicine.</gtr:title><gtr:parentPublicationTitle>Expert review of gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/52542eaf317f347220ec706e5b20b4a1"><gtr:id>52542eaf317f347220ec706e5b20b4a1</gtr:id><gtr:otherNames>Wang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1747-4124</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4FE2CA7E-D47C-4958-A2F9-0D4D12EEDEF6"><gtr:id>4FE2CA7E-D47C-4958-A2F9-0D4D12EEDEF6</gtr:id><gtr:title>Concise Review: Advances in Generating Hepatocytes from Pluripotent Stem Cells for Translational Medicine.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/064747e3ad60014f784c7bd6ae22e431"><gtr:id>064747e3ad60014f784c7bd6ae22e431</gtr:id><gtr:otherNames>Szkolnicka D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1C7411E3-2675-4052-BCC2-AD42D0D67AB2"><gtr:id>1C7411E3-2675-4052-BCC2-AD42D0D67AB2</gtr:id><gtr:title>Defined and Scalable Generation of Hepatocyte-like Cells from Human Pluripotent Stem Cells.</gtr:title><gtr:parentPublicationTitle>Journal of visualized experiments : JoVE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/52542eaf317f347220ec706e5b20b4a1"><gtr:id>52542eaf317f347220ec706e5b20b4a1</gtr:id><gtr:otherNames>Wang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1940-087X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7A1D9759-7FD0-48D8-B7D9-1C883EB1452F"><gtr:id>7A1D9759-7FD0-48D8-B7D9-1C883EB1452F</gtr:id><gtr:title>Hepatic progenitor cells of biliary origin with liver repopulation capacity.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/421e53c0612e3e95281d7e533db9ee5d"><gtr:id>421e53c0612e3e95281d7e533db9ee5d</gtr:id><gtr:otherNames>Lu WY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DFFB9E49-BE16-4B63-91FD-1A6713E4D51D"><gtr:id>DFFB9E49-BE16-4B63-91FD-1A6713E4D51D</gtr:id><gtr:title>Discovery of a Novel Polymer for Human Pluripotent Stem Cell Expansion and Multilineage Differentiation.</gtr:title><gtr:parentPublicationTitle>Advanced materials (Deerfield Beach, Fla.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/71778760bcfbaedc02a6e2939f7135ca"><gtr:id>71778760bcfbaedc02a6e2939f7135ca</gtr:id><gtr:otherNames>Celiz AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0935-9648</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DDF5F2FB-24AD-4020-89AD-874F9A73C24C"><gtr:id>DDF5F2FB-24AD-4020-89AD-874F9A73C24C</gtr:id><gtr:title>Stabilizing hepatocellular phenotype using optimized synthetic surfaces.</gtr:title><gtr:parentPublicationTitle>Journal of visualized experiments : JoVE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/086161dc37d1dafc22f0ce3f56c5730f"><gtr:id>086161dc37d1dafc22f0ce3f56c5730f</gtr:id><gtr:otherNames>Lucendo-Villarin B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1940-087X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/01DB0B02-4312-4375-B647-762122C0C61A"><gtr:id>01DB0B02-4312-4375-B647-762122C0C61A</gtr:id><gtr:title>Recombinant Laminins Drive the Differentiation and Self-Organization of hESC-Derived Hepatocytes.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a58d69ad4f17dd544ce82aba3158212b"><gtr:id>a58d69ad4f17dd544ce82aba3158212b</gtr:id><gtr:otherNames>Cameron K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/L022974/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>